HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1658
https://www.valueinhealthjournal.com/article/S1098-3015(22)03863-3/fulltext
Title :
HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03863-3&doi=10.1016/j.jval.2022.09.1658
First page :
Section Title :
Open access? :
No
Section Order :
11212